Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracil-responsive subgroup? by Iacopetta Barry, Kawakami Kazuyuki, Watanabe Toshiaki in International journal of clinical oncology / Japan Society of Clinical Oncology (2008).

[PMID: 19093176] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.